“Our task must be to free ourselves... by widening our circle of compassion to embrace all living creatures and the whole of nature and its beauty." 

- Albert Einstein

Covid-19: First Human Vaccine Trials Start

Updated: Mar 31, 2020

Ellis Jackson reveals encouraging news from US that human trials for a Covid-19 vaccine have started | Science and Sentience

Photo by Vital Sinkevich

The first human trials of a possible Covid-19 vaccine have begun in Seattle, Washington as of Monday 16th March. These trials are the first opportunity for scientists to evaluate the effectiveness of one potential vaccine against the virus developed by American company Moderna, in collaboration with the U.S. National Institutes of Health.

Four volunteers at the Kaiser Permanente research centre in Northern California received a jab containing a harmless genetic code copied from that of the coronavirus. This vaccine was developed 63 days after the genetic sequence of the virus was shared by Chinese authorities.

This is the first step of many in the clinical trials to understand the potential benefits of the vaccine prototype named mRNA-1273, and, if it works, what level of dosage is required to induce an immune response against the virus in its recipients.

"The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks,"